• About
  • Masthead
  • License Content
  • Advertise
  • Press Releases
  • Newsroom
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

Sign in
SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
    • Physician Pay by Specialty
    • ICD-10 Code Lookup
    • FDA Drug Approvals
    • Drug Safety for Breastfeeding/Pregnancy
    • Clinical Guidelines
    • Medical Calculators
    • ECG Reference
      • QTc Calculator
      • Sgarbossa Criteria
      • ECG Axis Calculator
      • AV Block Helper
  • Rankings
    • Medical School Rankings
    • Residency Rankings
  • Partners
    • License Content
    • Advertise with Us
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
    • Physician Pay by Specialty
    • ICD-10 Code Lookup
    • FDA Drug Approvals
    • Drug Safety for Breastfeeding/Pregnancy
    • Clinical Guidelines
    • Medical Calculators
    • ECG Reference
      • QTc Calculator
      • Sgarbossa Criteria
      • ECG Axis Calculator
      • AV Block Helper
  • Rankings
    • Medical School Rankings
    • Residency Rankings
  • Partners
    • License Content
    • Advertise with Us
Sign in
SUBSCRIBE
2 Minute Medicine
Sign in
Subscribe
2 Minute MedicineFree on Google PlayGet
✦EvidencePulse™by 2 Minute Medicine3 reportsYou askedtop stroke trials 2026Synthesizing medical evidence...Top 2026 stroke trial results:OCEANIC — ischemic stroke: 6.2% vs 8.4%OPTION* — mRS 0–1: 43.6% vs 34.2%ORIENTAL* — mRS 0–2: 58.6% vs 46.6%*Higher sICH in intervention armsParticipants randomizedNOCEANIC12,327OPTION570ORIENTAL564Ask about guidelines or landmark trials...↑Try EvidencePulse™Ask the evidence. Get the signal.Try it now →
Home All Specialties Obstetrics

Gender-associated sexual behavior linked to oral oncogenic HPV rates

byMaren ShapiroandLeah Hawkins Bressler, MD, MPH
April 18, 2015
in Obstetrics, Oncology
Reading Time: 3 mins read
Share on FacebookShare on TwitterShare on LinkedIn

1. Oral oncogenic HPV prevalence was more than 4 times higher among men than women.

2.The gender difference was due primarily to a higher number of lifetime sexual partners and a stronger association between sexual behavior and infection among men.

Evidence Rating Level: 3 (Average)

Study Rundown: It is widely known that the sexually transmitted human papillomavirus (HPV) causes cervical and genital cancers, but it was notv until the 1990s that researchers discovered the same infection was causing an increasing number of head and neck, and oropharyngeal, cancers. HPV is currently estimated to cause 70 percent of oropharyngeal cancers and by 2020, experts anticipate cases will continue increasing in number to surpass those of cervical cancer for the most common HPV associated malignancy. Interestingly, in multiple developed countries worldwide the incidence is rising more in men than in women. In the United States, men are 3 to 5 times more likely to have an HPV positive head and neck cancer. The reasons behind this difference remain unknown. In this study, a team of researchers led by Maura Gillison, one of the first to discover the connection between HPV and oral cancers, compared the epidemiology of oral oncologic HPV infections between men and women.

Findings demonstrated that oral oncogenic HPV prevalence was significantly higher among men than women. Men were found to have a higher number of lifetime sexual partners and a greater per-partner increased risk of infection compared to women. This result is in keeping with the hypothesis that there is a higher risk for HPV transmission when men perform oral sex, although gender differences in immune responses may also contribute.

Strengths of this study included a large, nationally representative sample. One notable limitation is that sexual activity was self-reported—it is well document that men tend to over-report, while women under-report sexual partners. Future studies comparing specific sexual behaviors and risk of HPV infection are warranted.

RELATED REPORTS

An artificial intelligence system for human papillomavirus-positive dual stain cervical cancer screening reads p16-Ki67 slides

Delayed CIN2 treatment does not increase cancer risk 

Click to read the study in Cancer Research

Relevant Reading: Case-Control Study of Human Papillomavirus and Oropharyngeal Cancer

In-Depth [cross-sectional study]: Participants in the U.S. National Health and Nutritional Examination Surveys (NHANES) from 2009-2012 who agreed to participate in the Oral HPV Protocol provided oral samples, which were analyzed for the presence of 37 HPV types (n=9,480). Incidence of oral oncogenic HPV infection was compared with self-reported data on sexual practices, tobacco, alcohol and drug use.

The prevalence of oral oncogenic HPV infections was higher in men than women (6.5% vs. 1.5%, p<0.001). For both genders, prevalence was directly associated with age, smoking, and lifetime number of sexual partners (all p<0.02). On average, men had more lifetime sexual partners than women (18 vs. 7, p<0.001). When stratified by number of partners, there was a difference in male-female prevalence that increased with number of lifetime partners, from 0.2% for women with one partner versus 0.6% for males with one partner to 3.7% for women with over 20 partners partners and 13.9% of men with over 20 partners partners (both p<0.05).

Image: PD

©2015 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: cervical cancergenital wartsHuman Papilloma Virus (HPV)
Previous Post

The ORACLE trial: Antibiotics for preterm, prelabor rupture of membranes [Classics Series]

Next Post

Non-invasive prenatal testing linked to decreased diagnostic testing

RelatedReports

A calendar, a specimen jar, and a brush are depicted alongside a microscopic view of cervical cells, indicating cervical cancer screening.
All Specialties

An artificial intelligence system for human papillomavirus-positive dual stain cervical cancer screening reads p16-Ki67 slides

October 23, 2026
Cervical cancer screening practices less cost-effective than suggested guidelines
Oncology

Delayed CIN2 treatment does not increase cancer risk 

June 22, 2026
Quick Take: T-Cell Receptor Gene Therapy for Human Papillomavirus–Associated Epithelial Cancers: A First-in-Human, Phase I/II Study
Chronic Disease

The quadrivalent human papillomavirus vaccine provides effective and durable protection against invasive cervical cancer

March 6, 2026
Physical fitness collage: a smiling woman in a swim cap with goggles pushed up, in front of a pool lane rope and water
Weekly Rewinds

2 Minute Medicine Rewind March 2, 2026

March 2, 2026
Next Post

Non-invasive prenatal testing linked to decreased diagnostic testing

Forearm parathyroid reimplantation may be effective in preventing hypoparathyroidism

Forearm parathyroid reimplantation may be effective in preventing hypoparathyroidism

Salvage esophagectomy may improve survival in patients with esophageal cancer

✦ EvidencePulse™ by 2 Minute Medicine 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... Try EvidencePulse™ Get the signal. Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

3-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Removing Race and Ethnicity From Dialysis Mortality Risk Adjustment Changes Facility Performance Rankings
  • AI Model Shows Promise in Predicting PTSD Risk Following Trauma
  • 2 Minute Medicine Rewind November 16, 2026
License Content
Terms of Use | Disclaimer
Cookie Policy

Get the app

Read 2 Minute Medicine on iPhone, iPad and Android.

Download on the App StoreGet it on Google Play
QR code for www.2minutemedicine.com/app
On a computer? Scan this with your phone’s camera.
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

3-day free trial · cancel anytime

Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free

Start 3-day free trial

Then $49.90/year.

Membership benefits

  • ✓100+ new physician-written study summaries monthly, 12,000+ searchable
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
  • ✓FDA drug approvals + clinical calculators

Already a member? Sign in

  • Get the app
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
    • Physician Pay by Specialty
    • ICD-10 Code Lookup
    • FDA Drug Approvals
    • Drug Safety for Breastfeeding/Pregnancy
    • Clinical Guidelines
    • Medical Calculators
    • ECG Reference
      • QTc Calculator
      • Sgarbossa Criteria
      • ECG Axis Calculator
      • AV Block Helper
  • Rankings
    • Medical School Rankings
    • Residency Rankings
  • Partners
    • License Content
    • Advertise with Us
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.